NEPHROS, INC. Capital Expenditures
NEPHROS, INC. (NEPH) reported Capital Expenditures of $55.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-12
- NEPHROS, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- NEPHROS, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00.
- NEPHROS, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $0.00.
- NEPHROS, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- NEPHROS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $55.00K, a 26.67% decline from fiscal 2023.
- NEPHROS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $75.00K, a 45.26% decline from fiscal 2022.
- NEPHROS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $137.00K, a 280.56% increase from fiscal 2021.
- NEPHROS, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $36.00K, a 84.94% decline from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $55.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $55.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $55.00K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $75.00K 10-K · filed 2025-03-24 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-15 | $103.00K derived: sum of 3 quarters · filed 2024-03-15 | $137.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $103.00K derived: sum of 2 quarters · filed 2023-11-08 | $137.00K 10-Q · filed 2023-11-08 | $137.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $137.00K 10-Q · filed 2023-08-09 | $137.00K derived: sum of 3 quarters · filed 2023-08-09 | $150.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $34.00K 10-Q · filed 2023-05-10 | $34.00K derived: sum of 2 quarters · filed 2023-05-10 | $47.00K derived: sum of 3 quarters · filed 2023-05-10 | $47.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $13.00K derived: sum of 2 quarters · filed 2023-03-23 | $13.00K derived: sum of 3 quarters · filed 2023-03-23 | $36.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-15 | $13.00K derived: sum of 2 quarters · filed 2022-11-15 | $36.00K 10-Q · filed 2022-11-15 | $36.00K derived: sum of 4 quarters · filed 2022-11-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $23.00K 10-Q · filed 2022-08-15 | $23.00K derived: sum of 3 quarters · filed 2022-08-15 | $36.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $23.00K 10-Q · filed 2022-05-05 | $23.00K derived: sum of 2 quarters · filed 2022-05-05 | $36.00K derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $13.00K derived: sum of 2 quarters · filed 2022-03-03 | $239.00K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $239.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $226.00K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $14.00K 10-K · filed 2021-03-01 | ||
| 2019-09-30 | $14.00K 10-Q · filed 2020-11-05 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $5.00K derived: sum of 2 quarters · filed 2018-02-26 | $19.00K derived: sum of 3 quarters · filed 2018-02-26 | $45.00K 10-K · filed 2018-02-26 |
| 2016-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $19.00K derived: sum of 2 quarters · filed 2017-11-09 | $45.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $40.00K 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $26.00K 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | $13.00K 10-K · filed 2017-03-20 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-28 | |||
| 2012-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $1.00K derived: sum of 2 quarters · filed 2014-03-28 | $8.00K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $7.00K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $7.00K 10-Q · filed 2013-08-13 | |||
| 2010-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $30.00K 10-K · filed 2012-03-22 | ||
| 2010-09-30 | $6.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |